United States · FDA National Drug Code directory
Linezolid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-183_008b01d8-4425-4317-a172-4cc2a9e4e39d
- Product NDC
- 62332-183
- Form
- TABLET, FILM COATED
- Composition / generic term
- Linezolid
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151222
- Source listing expiry
- 20261231
Source-listed ingredients
- LINEZOLID — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE (62332-183-20) · 62332-183-20
- 30 TABLET, FILM COATED in 1 BOTTLE (62332-183-30) · 62332-183-30
- 100 TABLET, FILM COATED in 1 BOTTLE (62332-183-31) · 62332-183-31
- 1000 TABLET, FILM COATED in 1 BOTTLE (62332-183-91) · 62332-183-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →